Page E Crew

Disseminated gonococcal infections in patients receiving eculizumab: a case series.

R. Kirkcaldy, K. Bernstein, P. Waldron, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel

C. Coopersmith, D. Glidden, P. Belperio, 2020, Annals of Internal Medicine.

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Karla P. Zepeda, Christina C. Chang, Kamil H A Kim, 2022, Annals of Internal Medicine.

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

Rebecca M. Baker, Phuong Thi Tuyet Nguyen, Carol L. Eyler, 2021, The Lancet Infectious Diseases.

Unusual Neisseria species as a cause of infection in patients taking eculizumab.

P. Waldron, L. McNamara, Page E. Crew, 2019, The Journal of infection.

Correlation between hospital‐level antibiotic consumption and incident health care facility‐onset Clostridium difficile infection

S. Sutton, M. Scheetz, Cristina M Miglis, 2017, American journal of infection control.

Days of Therapy and Antimicrobial Days: Similarities and Differences Between Consumption Metrics

S. Davis, M. Scheetz, Jamie L. Wagner, 2016, Infection Control & Hospital Epidemiology.

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

Michael L. Nelson, Brad T. Sherman, I. Douglas, 2023, The Lancet Respiratory Medicine.